- Home
- Products
- Prescription: cardiometabolic
- Furosemide-Darnitsa
Furosemide-Darnitsa
Release forms:
- Solution for injection
- Tablet
– Oedemas in chronic congestive heart failure (if treatment with diuretics is required).
– Oedemas in nephrotic syndrome (if treatment with diuretics is required).
– Oedemas in chronic renal failure.
– Acute renal failure, including in pregnant women or during childbirth.
– Oedemas in liver diseases (if required to supplement the treatment with aldosterone antagonists).
– Hypertension.
Characteristics of the productу:
- Release formThe tablet is indivisible
- ChildrenWith caution
- PregnantContraindicated
- NursingContraindicated
- Release categoryPrescription medication
- AllergicsWith caution
- DiabeticsAllowed
- DriversContraindicated
- Temperature storage conditionsNot higher than 25 °С
- Qualitative and quantitative composition
- Pharmaceutical form
- Pharmacotherapeutic group
- Pharmacological properties.
- Clinical particulars
- Therapeutic indications.
- Contraindications.
- Interaction with other medicinal products and other forms of interaction.
- Special warnings and precautions for use.
- Posology and method of administration.
- Overdose.
- Undesirable effects.
- Shelf life.
- Special precaution for storage.
- Nature and contents of container
- Category of release
- Manufacturer
- The manufacturer's location and address of the place of business
- Date of last revision